Diabetic retinopathy is one of the leading causes of preventable blindness in working-age adults, and its burden is rising across Africa as diabetes prevalence grows. For ophthalmology departments building meaningful retina services, a reliable photocoagulation laser is one of the highest-impact investments available.
Why photocoagulation matters
Retinal laser photocoagulation is a proven, cost-effective treatment for diabetic retinopathy and related retinal indications such as retinal tears. Delivered in outpatient settings, it can preserve vision for thousands of patients over an instrument's lifetime — making it a priority for public-sector and faith-based eye programmes alike.
The Vitra 2 photocoagulator
The Vitra 2 is Quantel Medical's multipurpose 532 nm photocoagulator for retinal treatment, offering SingleSpot and MultiSpot delivery according to the manufacturer's official product information. SingleSpot delivery supports conventional treatment patterns, while MultiSpot delivery allows photocoagulation to be applied in shorter, better-tolerated sessions — a practical advantage in busy clinics. Clinical specifications should be confirmed from the official brochure during procurement.
Planning a retina laser service
Eye departments should plan for: the treatment room and power environment, surgeon and nurse training on the platform, consumables supply, and preventive maintenance to keep the laser in calibration. Confirming all of this before delivery avoids costly idle time.
How KRIMS helps
KRIMS Meditech Solutions sources ophthalmic equipment from verified original manufacturers such as Quantel Medical and supports eye departments across Africa with procurement, installation, commissioning and service enquiries. To request a quotation for the Vitra 2, request a quote through KRIMS.
